At Corealis Pharma, our toxicology formulation services are designed to move your program from discovery to clinic with confidence. We create purpose-built preclinical formulations that ensure stability, compatibility, and optimized bioavailability—laying the groundwork for successful PK/TK, PD, and TD studies.
Our team applies the same rigor and infrastructure used in clinical development:
- Comprehensive API characterization (particle size, morphology, hygroscopicity, XRPD, DSC, TGA)
- Solubility and stability testing in biorelevant media
- Dose recovery and accuracy assessments for in-use scenarios
- PK/TK study design and interpretation to guide dose selection
- With integrated services spanning formulation design, analytics, GMP manufacturing, and global clinical supply, Corealis provides a seamless pathway to First-in-Human trials.
For inquiries, please contact:
Patrick Frankham, VP Business Development
Corealis Pharma Inc.
Email: patrick.frankham@corealispharma.com
Phone: +1 (450) 973-7505
www.corealispharma.com
Contact Corealis
Corealis’ experts are ready to answer any queries about the company’s oral solid dose offering, including its development and manufacturing capabilities.
